Bill

Bill > A2204


NJ A2204

NJ A2204
"Pharmaceutical Representative Licensing Act."


summary

Introduced
02/07/2022
In Committee
02/07/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

"Pharmaceutical Representative Licensing Act."

AI Summary

This bill establishes the "Pharmaceutical Representative Licensing Act" in New Jersey. It requires individuals who engage in the marketing or promotion of pharmaceuticals to practitioners to be licensed by the State Board of Medical Examiners. The bill sets forth the board's powers and duties, including establishing educational and experience requirements for licensure, issuing and renewing licenses, and enforcing professional conduct standards. It also mandates continuing education requirements for licensed pharmaceutical representatives and requires them to provide detailed reporting on their interactions with practitioners. The bill aims to ensure proper conduct and transparency in the pharmaceutical marketing industry.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced, Referred to Assembly Regulated Professions Committee (on 02/07/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...